Autolus Therapeutics
AUTL · NASDAQ
$1.66+$0.07 (+4.40%)TodayMarket closed ·
Prev close $1.59
Who owns AUTL
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 70.1% of AUTL’s shares.
- MAK Capital One, LLC12.6%
- BioNTech SE12.5%
- Clarus Ventures, LLC7.7%
- Blackstone Inc.7.7%
- Next 6 largest institutions29.6%
- All other shareholders29.9%
| Holder | Shares | % of shares |
|---|---|---|
| MAK Capital One, LLC | 33.62M | 12.63% |
| BioNTech SE | 33.33M | 12.52% |
| Clarus Ventures, LLC | 20.49M | 7.70% |
| Blackstone Inc. | 20.49M | 7.70% |
| Syncona Portfolio Ltd | 16.64M | 6.25% |
| Armistice Capital LLC | 15.00M | 5.64% |
| Qatar Investment Authority | 15.00M | 5.64% |
| PPF Group N.V. | 14.78M | 5.55% |
| Polygon Management Ltd. | 9.50M | 3.57% |
| Schroder Investment Management Ltd. (SIM) | 7.83M | 2.94% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| AXA Framlington Health Fund | 3.36M | 1.26% |
| iShares Biotechnology ETF | 1.50M | 0.56% |
| JPM Thematics - Genetic Therapies | 889.48K | 0.33% |
| MGTS Sentinel Navigator Fund | 287.15K | 0.11% |
| Tema Oncology ETF | 268.13K | 0.10% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $15.68K (1 trade) of AUTL on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Piccina Cintia | Sale | 6.71K | $15.68K |
| Piccina Cintia | Option exercise | 20.00K | — |
| Piccina Cintia | Option exercise | 20.00K | $47.00K |
| Rao Madduri Ravin | Award | 47.50K | — |
| Rao Madduri Ravin | Award | 31.67K | — |
| Richardson Ryan | Award | 47.50K | — |
| Richardson Ryan | Award | 31.67K | — |
| Leiderman Elisabeth | Award | 47.50K | — |
| Leiderman Elisabeth | Award | 31.67K | — |
| Iannone Robert | Award | 47.50K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 8.40M
- Days to cover
- 5.66
- % of shares outstanding
- 3.16%
- Average daily volume
- 1.48M
- Change since last report
- +0.9%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.